Circulation, Vol 75, 643-650, Copyright © 1987 by American Heart Association
MD Thames, UJ Johannsen and AL Mark
Injection of serotonin (5-HT) into the left atrium or ventricle activates a
hypertensive chemoreflex. The primary purpose of our study was to determine
the afferent pathway(s) that mediates this response. A secondary goal was
to localize the receptive sites of this reflex. We measured changes in
arterial pressure, reflex vascular responses in skeletal muscle and paw,
and changes in renal nerve traffic that occurred after the left atrial or
left ventricular injection of 5-HT. Injection of 5-HT (100 to 600
micrograms) into left atrium or ventricle produced large reflex increases
in vascular resistance and sympathetic outflow. These responses were not
reduced after bilateral cervical vagotomy. In separate experiments,
increases in renal nerve traffic with left ventricular injection of 5-HT
were assessed before and after cardiac sympathetic deafferentation.
Interruption of cardiac sympathetic afferent pathways did not significantly
attenuate increases in renal nerve activity with 5-HT. Injection of 5-HT
(300 micrograms) into the aortic root produced large increases in arterial
pressure but this was not observed after injections into the vertebral or
common carotid arteries or descending aorta. Injection of 5-HT (100
micrograms) into the left main coronary artery (perfused via a Gregg
cannula from an external reservoir) resulted in a depressor reflex
(Bezold-Jarisch). In contrast, injection of 5-HT (200 micrograms) into the
left ventricle when the drug was prevented from reaching the left coronary
artery produced a large pressor response.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
In search of afferent pathways of a cardiogenic hypertensive chemoreflex
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |